DEEPULL

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functional status on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.

#SimilarOrganizations #People #Financial #More

DEEPULL

Industry:
Biotechnology Life Science

Founded:
2019-01-01

Address:
Barcelona, Catalonia, Spain

Country:
Spain

Total Employee:
1+

Status:
Active

Total Funding:
3.5 M EUR


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

bright-peak-therapeutics-logo

Bright Peak Therapeutics

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

demetrix-logo

Demetrix

Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

rnaimmune-logo

RNAimmune

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

Current Employees Featured

jordi-carrera_image

Jordi Carrera
Jordi Carrera Co-Founder & Chief Executive Officer @ DeepUll
Co-Founder & Chief Executive Officer
2019-09-01

rafel-bru_image

Rafel Bru
Rafel Bru Co-Founder & Chief Technology Officer @ DeepUll
Co-Founder & Chief Technology Officer

Founder


jordi-carrera_image

Jordi Carrera

rafel-bru_image

Rafel Bru

Investors List

alta-life-sciences_image

Alta Life Sciences

Alta Life Sciences investment in Series A - DeepUll

kurma-life-science-partners_image

Kurma Partners

Kurma Partners investment in Series A - DeepUll

More informations about "DeepUll"

Deepull

Furthermore, confirming and identifying the underlying infection is a complicated and time-consuming task for the hospital laboratory. The need for faster, more sensitive diagnostic technology has been a recognized unmet medical need for decades. This is the challenge that …See details»

DeepUll - Crunchbase Company Profile & Funding

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.See details»

DeepUll Company Profile 2024: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for DeepUll. Use the PitchBook Platform to explore the full profile.See details»

deepull - LinkedIn

Deepull Biotechnology Research deepull is a development-stage clinical diagnostics company focusing on direct from blood sepsis diagnostics.See details»

DeepUll - Funding, Financials, Valuation & Investors

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.See details»

Spain: €20 million EIB loan to DeepUll accelerates early …

Dec 13, 2022 The European Investment Bank (EIB) is providing DeepUll, a medical diagnostics company developing culture-free, affordable diagnostic solutions for the early identification of sepsis and other acute infections, with a …See details»

DeepUll - Updates, News, Events, Signals & Triggers

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.See details»

DeepUll Company Profile - Office Locations, Competitors, Revenue ...

DeepUll has 5 employees at their 1 location and $16.7 m in total funding,. See insights on DeepUll including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»

Sepsis Testing Startup DeepUll Raises €13M | GenomeWeb

Oct 20, 2022 DeepUll was founded two years ago by Carrera and Rafel Bru, the cofounders of Stat-Dx. That company offered a multiplex platform for infectious disease testing and was …See details»

DeepUll Raises $13 Million in Series B - The SaaS News

Oct 24, 2022 DeepUll, a Barcelona, Spain-based medical diagnostics company, announced that it raised €13 million in a Series B round of funding. The round was led by new investors …See details»

Spain-based DeepUll raises €13M to advance it early sepsis …

Barcelona-based DeepUll, a medical diagnostics company has raised €13M in a Series B round of funding led by Innvierte.See details»

deepull receives FDA Breakthrough Device Designation for its …

Dec 5, 2024 deepull, a medical device company developing culture-free diagnostic solutions for rapid pathogen identification, announced today that it has received Breakthrough Device …See details»

FDA grants breakthrough device designation to deepull’s BSI test

Dec 2, 2024 The US Food and Drug Administration (FDA) has granted breakthrough device designation to deepull’s UllCORE bloodstream infection (BSI) test. The test, which provides …See details»

deepull receives FDA Breakthrough Device Designation for

Dec 2, 2024 Jordi Carrera, Chief Executive Officer and Co-Founder of deepull, said: “We are thrilled to receive breakthrough designation from the FDA.See details»

☑️deepull — Consulting Organization from Spain — Health sector

About deepull is a development-stage clinical diagnostics company focusing on direct from blood sepsis diagnostics. We are based in Barcelona, Spain.See details»

Deepull - Asabys Partners

DeepUll is a medical diagnostics company developing culture-free diagnostic solutions for sepsis and acute infections. Founded in 2020 in Barcelona by the founders of STAT-Dx (sold to …See details»

FDA grants breakthrough device designation to DeepUll's …

Dec 4, 2024 Diagnostics developer DeepUll has received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its rapid bloodstream infection test. The …See details»

DeepUll - Contacts, Employees, Board Members, Advisors & Alumni

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.See details»

Meyer leads DePaul against St. John's after 23-point performance

2 days ago DePaul visits the St. John's Red Storm after Jacob Meyer scored 23 points in the Blue Demons' 91-72 win against the Wichita State Shockers.See details»

Series B - DeepUll - 2023-03-01 - Crunchbase Funding Round Profile

Mar 1, 2023 Asabys Partners - Investing across the board in human healthcare — Sabadell Asabys invests in DeepUll extending its Series B to €17MSee details»

linkstock.net © 2022. All rights reserved